product specific guidances webinar – opening remarks
Published 3 years ago • 2K plays • Length 12:57Download video MP4
Download video MP3
Similar videos
-
1:02:16
panel discussion on product-specific guidances
-
19:15
bioequivalence regulations and product-specific guidances
-
4:55
product specific guidances - closing remarks
-
3:01:55
facilitating generic drug product development through product-specific guidances
-
13:21
overview of the fda product-specific guidance program
-
14:41
product-specific guidance fundamentals from a clinical perspective
-
53:23
fda webinar on the infant formula transition plan for exercise of enforcement discretion (part 1)
-
57:22
fda webinar on new infant formula transition plan (part 2)
-
7:12:31
advancing generic drug development: translating science to approval 2024 (day 1)
-
2:03:33
a deep dive: fda’s model-integrated evidence (mie) industry meeting pilot program for generic drugs
-
28:23
fda product regulations part 1 of 7
-
2:34:13
public webinar: patient-focused drug development draft guidance 3
-
39:41
referencing approved drug products in anda submissions
-
24:07
filing review basics – examples of refuse-to-receive (rtr) (15of27) generic drugs forum 2018
-
58:05
best practices for topical generic product development & anda submission–session 3, closing remarks
-
25:59
fda’s inactive ingredient database (iid) (3of35) complex generics – sep. 25-26, 2019
-
38:20
office of pharmaceutical quality (opq) reorganization webinar
-
50:52
navigating fda's drug information resources
-
19:31
an overview of pre-license inspections for biotech products (5/15) global quality
-
41:47
structured product labeling format: an introduction (2/2) rems webinar – jun. 15, 2017
-
36:40
fda webinar on the infant formula food ingredients requirements
-
55:12
ich q12 guidance and emerging technology program (11of16) generic drugs forum 2020